A leadless cardiac pacemaker device configured to provide intracardiac pacing

The leadless pacemaker device addresses the challenge of atrial event detection by using dual processing channels with different gains and filtering techniques to achieve precise atrial sensing, ensuring effective atrioventricular synchronization and improved cardiac function.

JP7591573B2Active Publication Date: 2024-11-28BIOTRONIK SE & CO KG
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2022539645
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-03-11
Filing Date
2020-12-21
Publication Date
2024-11-28
Estimated Expiration
2040-12-21

AI Technical Summary

Technical Problem

Current leadless pacemakers lack the capability for reliable atrioventricular synchronization through effective sensing of atrial events, particularly due to the challenges in distinguishing small atrial signals from ventricular signals, which are often masked by external factors.

Method used

A leadless cardiac pacemaker device with dual processing channels, one for near-field ventricular signals and another for far-field atrial signals, utilizing different gains to enhance the detection of atrial events, employing bandpass filtering, blanking windows, and morphological analysis to ensure accurate atrial sensing.

Benefits of technology

Enables reliable atrioventricular synchronization by accurately detecting atrial events, improving pacing consistency and reducing interference from external factors, thus enhancing cardiac hemodynamics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007591573000001
    Figure 0007591573000001
  • Figure 0007591573000002
    Figure 0007591573000002
  • Figure 0007591573000003
    Figure 0007591573000003
Patent Text Reader

Abstract

A leadless pacemaker device (1) configured to provide intracardiac pacing comprises a housing (10), an electrode configuration disposed on the housing (10) configured to receive electrical signals, and processing circuitry (15) enclosed within the housing (10) and operatively connected to the electrode configuration, the processing circuitry (15) comprising a first processing channel (16) having a first gain G1 for processing a first processed signal derived from the electrical signal received via the electrode configuration, and a second processing channel (17) having a second gain G2 for processing a second processed signal derived from the electrical signal received via the electrode configuration, the second gain G2 being greater than the first gain G1.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates generally to leadless cardiac pacemaker devices for providing intracardiac pacing, particularly ventricular pacing, and more particularly VDD pacing. [Background technology]

[0002] In recent years, there has been increasing interest in leadless pacemakers. In contrast to subcutaneously implanted pacemakers that use leads that extend into the heart via a vein, leadless pacemakers do not use leads because the pacemaker device itself is implanted within the heart and the pacemaker has the shape of a capsule that is implanted into cardiac tissue, specifically the right ventricular wall of the right ventricle. Such leadless pacemakers offer the inherent advantage of being lead-free, thereby reducing patient risks associated with leads reaching the heart via a vein, such as pneumothorax, lead dislodgement, cardiac perforation, and venous thrombosis.

[0003] A leadless pacemaker may be specifically designed for implantation in the right ventricle, where it is placed in or on the wall of the right ventricle during implantation. Ventricular pacing may be indicated, for example, when there is dysfunction in the AV node but sinus node function is intact and adequate. In such cases, VDD pacing may be specifically desired, which includes ventricular pacing with atrial tracking, thus requiring sensing of atrial activity to pace the ventricles based on intrinsic atrial contractions.

[0004] VDD pacing is specifically motivated by the hemodynamic benefits to the patient: maximizing ventricular preload, limiting AV valve regurgitation, maintaining low mean atrial pressure, and atrioventricular (AV) synchrony by utilizing adequate sinus node function to trigger ventricular pacing, which may allow modulation of autonomic and neurohumoral reflexes.

[0005] To the applicant's knowledge, there are currently no commercially available VDD intracardiac leadless pacemakers, although solutions have been explored in the literature to use modalities for detecting the mechanical event of atrial contraction, including sensing motion, sound, and pressure (see, e.g., U.S. Patent Application Publication No. 2018 / 0021581(A1), which discloses a leadless cardiac pacemaker including a pressure sensor and / or accelerometer for determining atrial contraction timing). Detecting mechanical event-based signals, such as motion, sound, or pressure, can be challenging because the mechanical event produced by atrial contraction typically exhibits a small amount of signal when sensed from the ventricle. Furthermore, wall motion and blood movement caused by atrial contraction may not be transmitted directly to the ventricle, and cardiac hemodynamic signals, such as motion, heart sounds, and pressure, can be easily affected by external factors such as posture and patient activity. [Prior art documents] [Patent documents]

[0006] [Patent Document 1] US Patent Application Publication No. 2018 / 0021581(A1) Summary of the Invention [Problem to be solved by the invention]

[0007] In particular, it is an object to provide a leadless pacemaker device, and a method for operating a leadless pacemaker device, that enables ventricular pacing with atrioventricular synchrony and therefore requires reliable sensing of atrial events in order to provide ventricular pacing based on such events. [Means for solving the problem]

[0008] Such needs are addressed by a leadless cardiac pacemaker device configured to provide intracardiac pacing having the features of claim 1 .

[0009] In one aspect, a pacemaker device includes a housing, an electrode configuration disposed on the housing and configured to receive an electrical signal, and processing circuitry enclosed within the housing and operably connected to the electrode configuration, the processing circuitry including a first processing channel having a first gain for processing a first processed signal derived from the electrical signal received via the electrode configuration, and a second processing channel having a second gain for processing a second processed signal derived from the electrical signal received via the electrode configuration. According to an embodiment, the second gain is higher than the first gain.

[0010] A leadless pacemaker device is configured to utilize multiple processed signals. To obtain such processed signals, an electrode configuration is provided, comprising one or more electrodes for receiving electrical signals from which the processed signals are derived. The processed signals herein can be obtained, for example, using one electrode pair each, and can be obtained using the same or different electrode pairs to obtain different processed signals. In this first case, a single electrical signal, such as an intracardiac electrogram, can be obtained from which different processed signals, i.e., a first processed signal and a second processed signal, which are separately processed, are derived. In the second case, separate electrical signals, e.g., related to a ventricular sensed signal and an atrial sensed signal (i.e., by applying sensing optimized for atrial sensing), can be received to derive the first processed signal and the second processed signal from such different electrical signals, e.g., using the same or different electrode pairs of the electrode configuration. In the latter case, the separate electrical signals can be processed, for example, in different processing channels of the processing circuitry, and the different processing channels are associated with different sensing circuitry. For example, one processing channel may be configured as a low gain processing channel for processing electrical signals characteristic of ventricular activity, and another processing channel may be configured as a high gain channel for processing electrical signals characteristic of atrial activity.

[0011] The different processed signals are processed in different processing paths of the processing circuitry. To this end, the processing circuitry comprises a first processing channel for processing a first processed signal, e.g., related to a near-field (especially ventricular) sensed signal, whose amplitude may be such that the first processing channel may have a relatively low gain depending on the placement of the leadless pacemaker device, e.g., in a ventricle of a patient's heart. Furthermore, the processing circuitry comprises a second processing channel for processing a second processed signal, which may be related to a far-field (e.g., atrial) sensed signal, whose amplitude may be smaller depending on the distance between the implantation location and the source of the signal, e.g., in the case of a leadless pacemaker device, e.g., in a ventricle. To enable robust processing of the second processed signal, the second processing channel has a higher gain than the first processing channel to enable proper analysis of features related to atrial activity in the received signal.

[0012] For example, when placing a leadless pacemaker device in a ventricle, atrial events can be difficult to discern in a standard ventricular sensed signal (e.g., obtained via a standard ventricular QRS sensing channel) because atrial activity occurs in the far field and the resulting P waves can exhibit small amplitudes relative to the QRS and T waves. For this reason, signal portions associated with far-field activity can be processed separately from signals associated with near-field activity in a second processing channel such that far-field events can be detected with higher reliability and improved timing accuracy in the second processing channel.

[0013] The housing provides a hermetic enclosure for the leadless pacemaker device which contains within the housing all components required for autonomous operation including processing circuitry, energy storage such as a battery, and electrical and electronic circuitry. The housing is fluid impermeable such that the leadless pacemaker device can be implanted in cardiac tissue and maintained therein for extended periods of time to provide continuous cardiac pacing operation.

[0014] In one aspect, the leadless pacemaker device can be placed in the right or left ventricle.

[0015] In one aspect, the leadless pacemaker device comprises a fixation device having at least one fixation element disposed at a distal end of a housing for anchoring the pacemaker device to intracardiac tissue, particularly a ventricular wall. In one embodiment, one or more fixation elements in the form of thin wires, such as tines made of Nitinol exhibiting a shape memory effect, can be provided. In another embodiment, the fixation element in the form of a screw anchor can be provided.

[0016] In one aspect, the electrode arrangement includes a first electrode disposed near a distal end of the housing such that when the pacemaker device is implanted, the first electrode is disposed on the cardiac tissue and in contact with the cardiac tissue in a location effective to inject a stimulation signal into the cardiac tissue to cause a pacing action, particularly ventricular pacing.

[0017] In one embodiment, the electrode arrangement comprises a second electrode formed by an electrode ring extending circumferentially around the housing. Alternatively, the second electrode may be formed by, for example, a patch or another conductive area formed on the housing. The second electrode is located at a distance from the distal end of the housing and thus from the first electrode located at the distal end.

[0018] In one example, the processing circuitry is configured to process a first signal sensed between a first electrode and a second electrode as the first processed signal. Such a first signal may be represented as a near-field vector to be received between a pair of electrodes consisting of the first electrode and the second electrode. Since the first electrode and the second electrode may be located at a relatively short distance from each other in one example, such an electrode pair is primarily suitable for receiving signals in close proximity to the leadless pacemaker device, i.e., within a near-field region within a cardiac chamber when the leadless pacemaker device is implanted within a cardiac chamber. The sensed signal received between the first electrode and the second electrode is provided to a first processing channel for processing, e.g., to detect near-field (e.g., ventricular) events in the signal.

[0019] In one embodiment, the housing comprises a distal end opposite the tip, and the electrode configuration comprises a third electrode disposed on the distal end of the housing opposite the tip, the third electrode operably connected to the processing circuitry such that the processing circuitry can receive and process signals received via the third electrode.

[0020] In one aspect, the processing circuitry is configured to process as the second processed signal a second signal sensed between the first electrode and the second or third electrode. Such a second signal vector arising between the first electrode and the second or third electrode may be referred to as a far-field vector, where the first electrode and the third electrode exhibit a greater distance relative to each other than the first and second electrodes. The second signal can be processed to detect an event in the far-field, i.e., an atrial contraction, such that the second signal can capture intrinsic atrial activity prior to injection of a pacing stimulus, particularly when the leadless pacemaker device is placed in a ventricle.

[0021] A second signal sensed between the first and third electrodes can be used to sense intrinsic atrial contractions to effect atrial and ventricular synchronization by injecting a timed stimulus following an atrial contraction at the implantation site of the pacemaker device in the ventricle. The second signal is provided to a second processing channel for processing the signal and detecting atrial events therefrom for the purpose of providing a pacing action based on the detected atrial events, thereby enabling ventricular pacing under atrioventricular (AV) synchronization.

[0022] In one aspect, the same set (or subset) of electrodes of the leadless pacemaker device are used for both sensing contraction signals and delivering pacing stimulation signals. To this end, in one example, processing circuitry of the leadless pacemaker device is configured to switch between a sensing mode and a stimulation mode by alternating between processing received signals and generating pacing signals. In particular, the processing circuitry can be configured to sense an atrial contraction during a first phase of a cardiac cycle. If an atrial contraction is detected, the processing circuitry can sense ventricular activity within a time delay after the sensed atrial event. If no ventricular activity is sensed, the pacemaker device can switch to a stimulation mode in which a pacing signal is generated and delivered using at least one of the first and second electrodes. After the pacing signal is delivered, pacing action can continue with a new sense of an atrial contraction.

[0023] In one example, the second processing channel comprises a processing stage for distinguishing one wave portion from another wave portion in the second processed signal. The processing stage may be configured to and may include, among other things, band-pass filtering, a blanking window for excluding parts of the second received signal from further processing, moving average filtering, and rectification to the second processed signal. The processing stage results in the separation and / or emphasis of wave portions in the signal to be processed that may be indicative of, for example, atrial events. When a leadless pacemaker device is placed in a chamber of a patient's heart, signal portions associated with far-field (e.g., atrial) activity may have a much smaller amplitude than signal portions associated with near-field (e.g., ventricular) activity. Thus, the processing serves to distinguish such signal portions in order to identify different signal portions that may include signals associated with far-field (atrial) activity, i.e. so-called P-waves.

[0024] To separate the P-waves, band-pass filtering may be applied, which distinguishes wave portions associated with P-waves from wave portions specifically associated with QRS and T-waves resulting from ventricular activity. Alternatively or additionally, blanking methods may be applied to nullify certain portions of the second processed signal, i.e., those portions that contain signal resulting from events other than far-field (e.g.) atrial activity. In this case, a blanking window serves to not reveal signal portions that are not important for the far-field activity, but may rather interfere with the detection of the far-field activity. By means of the blanking window, those portions of the signal that are not associated with far-field (e.g. atrial) activity are therefore excluded from processing, such that the processing is limited to signal portions that are (likely) associated with far-field activity. Alternatively or additionally, other methods may be applied, such as moving average filtering, finite differences, or rectification of the signal. A moving average filter may be used herein to smooth the processed signal. Rectification may serve to easily compare the processed signal to a (single) threshold value to identify when the magnitude of the signal exceeds a pre-determined threshold. The rectified processed signal may also be compared to an adjustable threshold value.

[0025] In one example, the first processing channel comprises a first detection stage for detecting at least one near-field event in the first received signal. Herein, a processing stage of the second processing channel may be configured to determine at least one limit value of a blanking window for excluding a portion of the second received signal from further processing based on the near-field (e.g. ventricular) event detected by the first detection stage of the first processing channel. The first processing channel is responsible for processing the processed signal with a lower gain to detect near-field events, i.e. events due to activity in close proximity to the implanted leadless pacemaker device, e.g. in the ventricle in which the leadless pacemaker device is implanted. Since near-field events will also be included in the second processed signal, it is advantageous to null such signal parts related to near-field activity, i.e. QRS and T waves when the leadless pacemaker device is placed in the ventricle. For the purpose of proper positioning of the blanking window, the detected near-field events may be taken into account, e.g. to determine a standard timing between atrial and ventricular events. From the detected near-field event it can be determined within what time range after the far-field event the near-field event will typically occur so that a blanking window defined by a start time and a stop time can be appropriately set to disable those portions of the second processed signal associated with near-field (ventricular) events.

[0026] The second processing channel may be at least partially turned off during the blanking window, for example to save power in the second high gain processing channel. The second processing channel may for example comprise an amplification stage for amplifying the second processed signal, and the amplification stage may be turned off for the duration of the blanking window, such that no power is consumed by amplification during the time interval of the blanking window.

[0027] In a detection window outside the blanking window, detection of a far-field (atrial) event occurs. A detection window herein may start (immediately) at the end of the preceding blanking window or may end at the beginning of the next blanking window. However, it is also conceivable that the detection window may start, for example, at some time delay after the end of the preceding blanking window. Between the end of the blanking window and the start of the detection window, the second processing channel may be fully functional and may process the associated second processed signal, but in this case no detection of a far-field (atrial) event occurs until the start of the detection window.

[0028] In one embodiment, the second processing channel comprises a second detection stage for detecting at least one far-field event in the second processed signal. The second detection stage may be logically located after the processing stage of the second processing channel such that the second detection stage receives the processed signal from the processing stage of the second processing channel. The second detection stage here serves to identify far-field (atrial) events in the second processed signal to output information related to the timing of the detected far-field events.

[0029] The second detection stage of the second processing channel may in particular be configured to detect an atrial event by comparing the second processed signal with a threshold value. If the magnitude of the second processed signal exceeds the threshold value, it may be concluded that a far-field event is present. The processing herein may be performed on a rectified signal, which allows the application of a single threshold value that can be compared with the rectified signal. However, it is also possible to identify a far-field (atrial) event in a non-rectified signal, for example by applying two threshold values, a positive threshold and a negative threshold, in which case a far-field (atrial) event is identified if the positive signal portion exceeds the positive threshold value and / or the (magnitude of) the negative signal portion exceeds the negative threshold value.

[0030] The thresholds herein may be adjustable. For example, the thresholds may be set based on the maximum and / or minimum values ​​of detected P-waves. The thresholds may be set, for example, according to a pre-determined percentage of the maximum or minimum value of a previously detected P-wave.

[0031] Alternatively or additionally, one or more morphological features of the second processed signal may be evaluated to determine or identify a far-field (atrial) event. Evaluating one or more morphological features herein may include determining an amplitude value, determining a duration of a wave portion, e.g., a P-wave, determining a number of threshold or zero crossings, and / or determining a position of the wave portion in a detection window.

[0032] In general, identifying far-field (atrial) events by comparing the second processed signal in the second processing channel with one or more thresholds allows for fast detection and identification of far-field (atrial) events. However, such detection may not be completely accurate in some cases, for example due to a limited signal-to-noise ratio of the far-field signal portion. In this case, to allow fast but accurate detection and identification of atrial events, it may be beneficial to confirm the far-field (atrial) events detected by comparison with the threshold by evaluating morphological features of the processed signal processed in the second processing channel. This makes it possible, for example, to confirm true P waves and to reject false detections resulting from noise, QRS complexes, or T waves. Since the evaluation of morphological features, for example by determining the length of the waveform, may require evaluation within a certain time interval, the confirmation may be made after some delay from the initial identification of the far-field (atrial) event detected by threshold crossing.

[0033] In this case, the far-field (atrium) may be preliminarily detected by a threshold crossing, causing the second processing channel to output, for example, an atrial sense marker, which is later cancelled if the morphological feature evaluation does not confirm an atrial event. Alternatively, the second processing channel may output an atrial sense marker only after confirmation by the morphological features, but at the expense of a potential delay in outputting the atrial sense marker relative to the occurrence of the actual P-wave.

[0034] In one aspect, the processing circuitry is configured to trigger a pacing signal based on at least one detected far-field (e.g., atrial) event. The leadless pacemaker device can provide synchronous pacing. To this end, a simulation signal to stimulate ventricular activity can be issued by the pacemaker device if intrinsic ventricular activity is not detected via the first processing channel within a defined delay time window.

[0035] In one embodiment, if a loss of far-field (atrial) tracking occurs, for example due to indistinguishable contraction features in the second processed signal, the far-field tracking may temporarily be unable to be based on electrical signals received by the electrode configuration until the far-field tracking features are again identified in the second processed signal. Pacing action (particularly for ventricular pacing) may then be timed using an alternative atrial sensor, such as a motion sensor, an impedance signal, or another indicator of atrial activity. Alternatively, pacing may be switched to an asynchronous pacing mode. If far-field activity cannot be tracked, the second processing channel may process the second processed signal to monitor continuously or at periodic intervals to determine when the far-field event returns within a detection window, which may be adjustable.

[0036] The various features and advantages of this invention can be more readily understood by reference to the following detailed description and the examples illustrated in the drawings. [Brief description of the drawings]

[0037] [Figure 1] 1 is a schematic diagram of the human heart. [Diagram 2] Schematic diagram of a leadless pacemaker device. [Diagram 3] Schematic diagram of a leadless pacemaker device showing signal vectors between different electrodes of the leadless pacemaker device. [Figure 4] FIG. 1 is a schematic diagram of processing circuitry in an embodiment of a leadless pacemaker device. [Figure 5A] FIG. 2 illustrates a first processed signal in the form of an intra-cardiac electrogram (IEGM) received by a first processing channel of the processing circuitry. [Figure 5B] FIG. 2 shows a second processed signal in its raw state before processing by a second processing channel. [Figure 5C] FIG. 4 shows a second processed signal after processing by a processing stage of a second processing channel. [Figure 5D] FIG. 2 illustrates the timing of ventricular and atrial events detected in a first processed signal and a second processed signal. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0038] Subsequently, embodiments of the present invention will be described in detail with reference to the drawings, in which like reference numerals indicate like structural elements, and in which:

[0039] It should be noted that these examples do not limit the invention, but merely represent illustrative examples.

[0040] The present invention proposes a leadless pacemaker device providing intracardiac pacing, in particular ventricular pacing, in particular so-called VDD pacing.

[0041] 1 shows a schematic diagram of a human heart with the right atrium RA, right ventricle RV, left atrium LA, and left ventricle LV, in which the so-called sinoatrial node SAN is located in the wall of the right atrium RA, which is formed by a group of cells capable of spontaneously generating electrical impulses that travel through the electrical conduction system of the heart and thus cause the heart to contract in order to pump blood through the heart. The atrioventricular node AVN is responsible for regulating electrical conduction between the atria and the ventricles and is located in the dorsal lower area of ​​the intraatrial septum, near the opening of the coronary sinus. Extending from the atrioventricular node AVN is the so-called HIS bundle H, which is composed exclusively of electrically conducting cardiac muscle cells and forms part of an electrical conduction system for transmitting electrical impulses from the atrioventricular node AVN around the right ventricle RV via the so-called right bundle branch RBB and around the left ventricle LV via the left bundle branch LBB.

[0042] When there is a block in the atrioventricular node AVN, the intrinsic electrical conduction system of the heart H may be disturbed, which may result in insufficient intrinsic stimulation of ventricular activity, i.e., insufficient or irregular contractions of the right ventricle RV and / or left ventricle LV. In such cases, pacing of the ventricular activity may be required by a pacemaker device, which stimulates ventricular activity by injecting stimulation energy into the intracardiac tissue, particularly the myocardium M.

[0043] Proposed within this text is the use of a leadless cardiac pacemaker device 1, as shown generally in Figure 1, for providing ventricular pacing.

[0044] Although typical leadless pacemaker devices are designed to sense ventricular activity by receiving electrical signals from the ventricle in which they are placed, RV, or LV, it may be desirable to provide a pacing action that achieves atrioventricular (AV) synchrony by providing pacing in the ventricle that is synchronized with intrinsic atrial activity. In such a pacing mode, also referred to as VDD pacing mode, it is necessary to sense atrial activity and identify such atrial events as associated with atrial contractions in order to pace the ventricle based on atrial events.

[0045] 2 and 3 , in one embodiment a leadless pacemaker device 1 configured, inter alia, for providing intracardiac pacing in a VDD pacing mode comprises a housing 10 enclosing electrical and electronic components for operating the leadless pacemaker device 1. Enclosed within the housing 10 is processing circuitry 15, which also comprises a communications interface for communicating with an external device, e.g., a programmer wand. Additionally enclosed within the housing 10 are electrical and electronic components, such as an energy store in the form of a battery. The housing 10 encloses the components received therein and has, for example, the shape of a cylindrical shaft, e.g., having a length of several centimeters.

[0046] The leadless pacemaker device 1 is to be implanted directly into intracardiac tissue M. To this end, the leadless pacemaker device 1 comprises in the region of the distal tip 100 a fixation device 14, e.g. in the form of a Nitinol wire, for engaging intracardiac tissue M to hold the leadless pacemaker device 1 fixedly on the tissue in the implanted state.

[0047] The leadless pacemaker device 1 does not include a lead, but rather receives signals related to cardiac activity and also delivers stimulation signals via an electrode arrangement disposed on the housing 10. In the embodiment shown in FIGUREs 2 and 3, the leadless pacemaker device 1 includes different electrodes 11, 12, 13 that form the electrode arrangement and serve to deliver pacing signals to intracardiac tissue M to provide pacing, as well as to sense electrical signals indicative of cardiac activity, in particular atrial and ventricular contractions.

[0048] The first electrode 11 is referred to herein as a pacing electrode. The first electrode 11 is disposed at a distal end 100 of the housing 10 and is configured to engage cardiac tissue M.

[0049] The second electrode 12 acts as a counter electrode to the first electrode 11, and the signal vector P generated between the first electrode 11 and the second electrode 12 provides a pacing vector P for issuing a pacing signal toward the intracardiac tissue M.

[0050] Furthermore, the second electrode 12 serves as a sensing electrode specifically for sensing signals related to ventricular contraction, and a signal vector V arises between the second electrode 12 and the first electrode 11, and this signal vector V is represented as a near-field vector.

[0051] The second electrode 12 is disposed at a distance from the first electrode 11 and has, for example, the shape of a ring extending circumferentially around the housing 10. The second electrode 12 is disposed, for example, at a distance of about 1 cm from the tip 100 of the housing 10 where the first electrode 11 is disposed.

[0052] 2 and 3 , the leadless pacemaker device 1 further comprises a third electrode 13 located at the distal end 101 of the housing 10 that serves as a sensing electrode for sensing signals indicative of cardiac activity in the far field. In particular, signal vector A originates between the third electrode 13 and the first electrode 11, signal vector A including, for example, a signal indicative of an atrial contraction, and is referred to as the far field vector.

[0053] The electrodes 11, 12, 13 are operatively connected to processing circuitry 15, which is configured to cause the first electrode 11 and the second electrode 12 to emit pacing signals for stimulating the ventricles. The processing circuitry 15 is further configured to process signals received via the electrodes 11, 12, 13 for sensing cardiac activity, in particular atrial and ventricular contractions.

[0054] To provide pacing in the ventricle in which the leadless pacemaker device 1 is placed, particularly to enable pacing in a VDD mode, sensing of atrial activity is required to detect atrial sense markers to time pacing in the ventricle to achieve atrioventricular (AV) synchrony. Thus, far-field signals, particularly from the right atrium RA (see Fig. 1 ), are sensed by the leadless pacemaker device 1 implanted on endocardial tissue M in the right ventricle RV to enable synchronous pacing in the right ventricle RV.

[0055] Referring now to FIGURE 4, the processing circuitry 15 in one embodiment comprises two processing channels 16, 17 for processing different processed signals related to ventricular and atrial activity. As typically used herein, an intracardiac electrogram (IEGM) includes signal portions related to ventricular activity (particularly QRS complexes) and atrial activity (particularly P waves) and signal portions related to atrial activity but arising from far-field sources and thus much less prominent and of much smaller amplitude than signal portions related to ventricular activity in the near-field, i.e., in close proximity to the implanted leadless pacemaker device 1. For this reason, the two processing channels 16, 17 are associated with different gains G1, G2, the first processing channel 16 serving to process a first processed signal to identify ventricular events with a relatively low gain G1 and the second processing channel 17 configured to process a second processed signal to identify atrial events with a significantly higher gain G2.

[0056] In particular, the first processing channel 16 is connected to the electrode arrangement consisting of the electrodes 11, 12, 13, and the first processing channel 16 is configured to specifically sense and process signals received via the electrodes 11, 12 (near-field vector V in Figures 2 and 3). The first processing channel 16 comprises a first amplification stage 161 having a gain G1 and, following the amplification stage 161, a detection stage 162 configured to identify a ventricular sensing marker Vs from the first processed signals processed in the first processing channel 16.

[0057] This is illustrated in FIGURE 5A. The first processed signal processed in the first processing channel 16 resembles an intracardiac electrogram (IEGM) acquired in the ventricle in which the leadless pacemaker device 1 is implanted, which includes portions related to ventricular and atrial activity, but the portion of the signal related to ventricular activity is much more prominent relative to the other signal portions (QRS complex visible in FIGURE 5A). The occurrence of a ventricular event, in particular the onset of the QRS complex, may be determined, for example by comparing the signal to a suitable threshold or by applying a morphology analysis, and the second processing channel 16 outputs a ventricular sense marker Vs indicative of such a ventricular event.

[0058] The second processing channel 17 is similarly connected to the electrode arrangement consisting of the electrodes 11, 12, 13, the second processing channel 17 being configured to process signals sensed specifically via the far-field vector A between the electrodes 11, 13 located at the distal end 100 and the distal end 101 of the housing 10 as shown in Figures 2 and 3. The second processing channel 17 comprises a second amplification stage 171 having a second gain G2, followed by a processing stage 172 and a second detection stage 173.

[0059] The processing stage 172 serves to pre-process the amplified second processed signal. The detection stage 173 then serves to evaluate and analyze the processed signal to identify atrial events within the second processed signal, after which the second processing channel 17 outputs an atrial sense marker As indicative of an atrial event detected in the processed signal.

[0060] To identify and analyze atrial events, the gain G2 of the second processing channel 17 can be (significantly) higher than the gain G1 of the first processing channel 16. As can be seen in Fig. 5B, which illustrates the second processed signal in its raw state before processing by the processing stage 172, this makes it possible to analyze signal portions related to atrial events, but which need to be distinguished from other signal portions, in particular signal portions related to ventricular events in the near field and therefore much stronger than signal portions originating from atrial events in the far field.

[0061] For example, band-pass filtering, partial blanking, smoothing by moving average filtering, and rectification may be performed within processing stage 172. First or second order differencing may be applied to remove non-zero baselines while improving P-wave detection.

[0062] 5C shows the signal after processing by the processing stage 172 in the second processing channel 17. In particular, during this processing, a blanking window T is inserted, which serves to mute the signal during those time intervals that are - most likely - not related to atrial activity. blank can be applied. The blanking window T blank The placement of is determined in the embodiment of FIG. 4 following identification of a preceding ventricular event by the first processing channel 16.

[0063] In particular, detection of a ventricular event in the first processing channel 16 may determine the timing between an atrial event and a ventricular event. blank The start and end points of can be set so that signal portions not related to atrial activity are excluded from processing. In this way, strong ventricular signals can be suppressed so that signal portions related to ventricular activity cannot interfere with the detection of atrial events.

[0064] Blanking window T blankDuring this time, the second processing channel 17 may be turned off. In particular, the amplifier stage 171 of the second processing channel 17 may be turned off to save power.

[0065] In general, atrial event detection is performed within a blanking window T blank In this specification, the detection window for detecting an atrial event is outside the preceding blanking window T blank Alternatively, the detection window may start at the end of a preceding blanking window T blank , in which case the signal processing in the second processing channel 17 may have a delay relative to the end of the preceding blanking window T blank , but detection of atrial events begins only after a certain delay.

[0066] Different means may be employed to detect an atrial event in the second processed signal processed in the second processing channel 17 to output an atrial sensing marker As shown in FIG. 5D.

[0067] To allow fast detection of atrial events, the signal may be rectified, for example in processing stage 172, and detection stage 173 is configured to monitor whether the processed signal exceeds a (positive) threshold. Alternatively, no rectification may be applied in processing stage 172, and detection stage 173 monitors for crossing of a positive or negative threshold (or both).

[0068] Such thresholds herein may be continuously adapted according to the detected P-wave amplitude. In particular, the threshold for the following cycle for the next atrial event detection may be set according to a predetermined percentage of the amplitude of the P-wave detected in the preceding cycle.

[0069] Monitoring threshold crossings allows for fast detection of atrial events, but at the expense of potentially reduced reliability. Thus, in one embodiment, further analysis, e.g., of morphological features of the signal, in particular of the detected P-wave, may be applied to confirm an atrial event or to reject an otherwise false detection of an atrial event. With respect to such morphological analysis, e.g., the amplitude of the detected P-wave, the duration of the detected P-wave, the number of threshold or zero crossings in the detected P-wave, and / or the position of the detected P-wave in the detection window may be evaluated. If the morphological analysis concludes that a true atrial event is present, the atrial event identified by the initial threshold crossing monitoring is confirmed. Otherwise, the atrial event is rejected as false.

[0070] Since morphology analysis requires evaluation of the signal within a certain time interval, confirmation or rejection by morphology analysis may occur with a delay relative to the identification following threshold crossing. It is possible here to output an atrial sensing marker, as already done in the initial identification by threshold crossing, then after morphology analysis, in order to cancel the atrial sensing marker in case of a false positive. Alternatively, the atrial sensing marker As may be output only after confirmation by morphology analysis, at the expense of an increased delay between the true occurrence of the P-wave and the output of the atrial sensing marker As.

[0071] The atrial sensing marker As output by the second processing channel 17 may be used to achieve ventricular synchronous pacing. To this end, following the detected atrial sensing marker As, it may be detected whether an intrinsic ventricular sensing marker Vs (output by the first processing channel 16) occurs within a pre-determined time delay window after the atrial sensing marker As, in which case no stimulation is required. If the ventricular sensing marker Vs is not detected, a stimulation pulse may be issued to cause synchronous pacing in the ventricles.

[0072] Conversely, asynchronous pacing can also be performed.

[0073] Utilizing far-field electrical signals received by the leadless pacemaker device can provide superior detection of far-field events, particularly atrial events when the leadless pacemaker device is implanted within a ventricle. Tracking of far-field events through the use and evaluation of electrical signals can enable improved consistency and reliability, especially with respect to external factors such as posture and patient activity. [Explanation of symbols]

[0074] 1 Leadless pacemaker device 10. Housing 100 Tip 101 Distal end 11 First electrode (pacing electrode) 12 Second electrode (pacing ring) 13 Third electrode 14 Fixed Devices 15 Processing circuit configuration 16 Processing Channels 160 Electrode structure 161 Amplification stage 162 Detection stage 17 Processing Channels 170 Electrode structure 171 Amplification stage 172 Processing stage 173 Detection stage A Atrial vector As Atrial Event AVN Atrioventricular Node G1, G2 gain H HIS bunch LA Left atrium LBB left leg LV left ventricle M: Cardiac tissue (myocardium) P pacing vector RA right atrium RBB right leg RV right ventricle SAN sinoatrial node T blank Blanking Window V ventricular vector Vs Ventricular Events

Claims

1. A leadless pacemaker device (1) configured to provide intracardiac pacing, comprising: A housing (10); an electrode configuration disposed on the housing (10) and configured to emit stimulation signals and receive electrical signals for providing the intracardiac pacing; a processing circuitry (15) enclosed within said housing (10) and operatively connected to said electrode configuration, said processing circuitry (15) comprising a first processing channel (16) having a first gain (G1) for processing a first processed signal derived from an electrical signal received via said electrode configuration, and a second processing channel (17) having a second gain (G2) for processing a second processed signal derived from an electrical signal received via said electrode configuration, said second gain (G2) being greater than said first gain (G1); said second processing channel (17) comprising a processing stage (172) configured to apply to said second processed signal a blanking window for excluding parts of said second processed signal from further processing, The leadless pacemaker device (1), wherein the second processing channel (17) comprises an amplifier stage (170) for amplifying the second processed signal, the amplifier stage (170) being turned off during the blanking window (Tblank).

2. 2. The leadless pacemaker device of claim 1, wherein the housing (10) comprises a distal end (100), and the electrode configuration comprises a first electrode (11) disposed on the distal end (100) for engaging endocardial tissue (M).

3. 3. The leadless pacemaker device of claim 2, wherein the electrode configuration comprises a second electrode formed by an electrode ring extending circumferentially around the housing and spaced apart from the tip.

4. 4. The leadless pacemaker device of claim 3, wherein the processing circuitry (15) is configured to process first and / or second signals sensed between the first electrode (11) and the second electrode (12) as the first and / or second processed signals.

5. 5. The leadless pacemaker device of claim 2, wherein the housing (10) comprises a distal end (101) opposite the tip end (100) and the electrode configuration comprises a third electrode (14) disposed proximate the distal end (101).

6. 6. The leadless pacemaker device of claim 5, wherein the processing circuitry (15) is configured to process first and / or second signals sensed between the first electrode (11) and the third electrode (13) as the first and / or second processed signals.

7. The leadless pacemaker device of any one of claims 1 to 6, wherein the processing circuitry (15) is configured to process the first processed signal to detect ventricular activity and to process the second processed signal to detect atrial activity.

8. 8. The leadless pacemaker device of any one of claims 1 to 7, wherein the first processing channel (16) comprises a first detection stage (162) for detecting at least one near-field event (Vs) in the first processed signal, and the processing stage (172) of the second processing channel (17) configured to determine at least one of a start and an end of a blanking window (Tblank) for excluding a portion of the second processed signal from further processing based on the at least one near-field event (Vs) detected by the first detection stage (162).

9. The leadless pacemaker device of any one of claims 1 to 8, wherein the second processing channel (17) comprises a second detection stage (173) for detecting at least one far-field event (As) in the second processed signal.

10. The second detection stage (173) comprises: and configured to detect the at least one far-field event (As) by at least one of comparing the second processed signal to a threshold and evaluating at least one morphological feature of the second processed signal, the evaluating the at least one morphological feature comprising: determining an amplitude value from the second processed signal; determining a duration of a wave portion of the second processed signal; determining a number of threshold crossings or zero crossings in the second processed signal; and The leadless pacemaker device of claim 9 , further comprising at least one of: determining a position of a wave portion in a detection window.

11. The leadless pacemaker device (1) of claim 9 or 10, wherein the processing circuitry (15) is configured to trigger a pacing signal based on at least one detected far-field event (As).

12. A method for operating a leadless pacemaker device (1), the leadless pacemaker device (1) being adapted to provide intracardiac pacing, the method comprising: Receiving an electrical signal using an electrode configuration disposed on a housing (10) of the leadless pacemaker device (1); processing a first processed signal and a second processed signal derived from an electrical signal received via the electrode configuration using a processing circuitry (15) enclosed within the housing (10) and operatively connected to the electrode configuration, the processing circuitry (15) comprising a first processing channel (16) having a first gain (G1) for processing the first processed signal and a second processing channel (17) having a second gain (G2) for processing the second processed signal, the second gain (G2) being higher than the first gain (G1); applying, by a processing stage (172) comprised in the second processing channel (17), to the second processed signal a blanking window for excluding parts of the second processed signal from further processing; amplifying the second processed signal by an amplifier stage (170) included in the second processing channel (17), the amplifier stage (170) being turned off during the blanking window (Tblank).

Citation Information

Patent Citations

  • Pacemaker tachycardia determination according to arrest 2:1 detection

    JP1998509908A

  • A cardiac therapy system using subcutaneously sensed P waves for resynchronization pacing management

    JP2019519326A

  • Leadless intra-cardiac medical device with dual chamber sensing through electrical and / or mechanical sensing

    US20130325081A1

  • Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system

    US20180021581A1

  • System and method for controlling cardiac pacing mode switching

    US20180028814A1